Abstract
Amphotericin B (AmB) is one of the few drugs able to prolong survival times in experimental scrapie and delays the accumulation of PrPres, a specific marker of this disease in the brain in vivo. Previous reports showed that the AmB effect is observed only if the drug is administered around the time of infection. In the present study, intracerebrally infected mice were treated with AmB or one of its derivatives, MS-8209, between 80 and 140 days postinoculation. We observed an increased incubation time and a delay in PrPres accumulation and glial fibrillary acidic protein gene expression. Treatment starting at 80 days postinoculation was as efficient as long-term treatment starting the day of inoculation. Our results indicate that polyene antibiotics may interfere, throughout the course of the experimental disease, with the propagation of the scrapie agent.
Full Text
The Full Text of this article is available as a PDF (294.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adjou K. T., Demaimay R., Lasmezas C., Deslys J. P., Seman M., Dormont D. MS-8209, a new amphotericin B derivative, provides enhanced efficacy in delaying hamster scrapie. Antimicrob Agents Chemother. 1995 Dec;39(12):2810–2812. doi: 10.1128/aac.39.12.2810. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Adjou K. T., Demaimay R., Lasmézas C. I., Seman M., Deslys J. P., Dormont D. Differential effects of a new amphotericin B derivative, MS-8209, on mouse BSE and scrapie: implications for the mechanism of action of polyene antibiotics. Res Virol. 1996 Jul-Aug;147(4):213–218. doi: 10.1016/0923-2516(96)89651-8. [DOI] [PubMed] [Google Scholar]
- Bolard J. How do the polyene macrolide antibiotics affect the cellular membrane properties? Biochim Biophys Acta. 1986 Dec 22;864(3-4):257–304. doi: 10.1016/0304-4157(86)90002-x. [DOI] [PubMed] [Google Scholar]
- Bolton D. C., McKinley M. P., Prusiner S. B. Identification of a protein that purifies with the scrapie prion. Science. 1982 Dec 24;218(4579):1309–1311. doi: 10.1126/science.6815801. [DOI] [PubMed] [Google Scholar]
- Brajtburg J., Elberg S., Schwartz D. R., Vertut-Croquin A., Schlessinger D., Kobayashi G. S., Medoff G. Involvement of oxidative damage in erythrocyte lysis induced by amphotericin B. Antimicrob Agents Chemother. 1985 Feb;27(2):172–176. doi: 10.1128/aac.27.2.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brandner S., Isenmann S., Raeber A., Fischer M., Sailer A., Kobayashi Y., Marino S., Weissmann C., Aguzzi A. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature. 1996 Jan 25;379(6563):339–343. doi: 10.1038/379339a0. [DOI] [PubMed] [Google Scholar]
- Brown D. R., Schmidt B., Kretzschmar H. A. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature. 1996 Mar 28;380(6572):345–347. doi: 10.1038/380345a0. [DOI] [PubMed] [Google Scholar]
- Bruce M. E., Fraser H. Scrapie strain variation and its implications. Curr Top Microbiol Immunol. 1991;172:125–138. doi: 10.1007/978-3-642-76540-7_8. [DOI] [PubMed] [Google Scholar]
- Büeler H., Aguzzi A., Sailer A., Greiner R. A., Autenried P., Aguet M., Weissmann C. Mice devoid of PrP are resistant to scrapie. Cell. 1993 Jul 2;73(7):1339–1347. doi: 10.1016/0092-8674(93)90360-3. [DOI] [PubMed] [Google Scholar]
- Casaccia P., Ladogana A., Xi Y. G., Ingrosso L., Pocchiari M., Silvestrini M. C., Cittadini A. Measurement of the concentration of amphotericin B in brain tissue of scrapie-infected hamsters with a simple and sensitive method. Antimicrob Agents Chemother. 1991 Jul;35(7):1486–1488. doi: 10.1128/aac.35.7.1486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Caughey B., Raymond G. J. Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J Virol. 1993 Feb;67(2):643–650. doi: 10.1128/jvi.67.2.643-650.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chesebro B., Race R., Wehrly K., Nishio J., Bloom M., Lechner D., Bergstrom S., Robbins K., Mayer L., Keith J. M. Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature. 1985 May 23;315(6017):331–333. doi: 10.1038/315331a0. [DOI] [PubMed] [Google Scholar]
- Demaimay R., Adjou K., Lasmézas C., Lazarini F., Cherifi K., Seman M., Deslys J. P., Dormont D. Pharmacological studies of a new derivative of amphotericin B, MS-8209, in mouse and hamster scrapie. J Gen Virol. 1994 Sep;75(Pt 9):2499–2503. doi: 10.1099/0022-1317-75-9-2499. [DOI] [PubMed] [Google Scholar]
- Diringer H., Ehlers B. Chemoprophylaxis of scrapie in mice. J Gen Virol. 1991 Feb;72(Pt 2):457–460. doi: 10.1099/0022-1317-72-2-457. [DOI] [PubMed] [Google Scholar]
- Dormont D., Delpech B., Delpech A., Courcel M. N., Viret J., Markovits P., Court L. Hyperproduction de protéine gliofibrillaire acid (GFA) au cours de l'évolution de la tremblante expérimentale de la souris. C R Seances Acad Sci III. 1981 Jul 6;293(1):53–56. [PubMed] [Google Scholar]
- Ehlers B., Diringer H. Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen. J Gen Virol. 1984 Aug;65(Pt 8):1325–1330. doi: 10.1099/0022-1317-65-8-1325. [DOI] [PubMed] [Google Scholar]
- Ingrosso L., Ladogana A., Pocchiari M. Congo red prolongs the incubation period in scrapie-infected hamsters. J Virol. 1995 Jan;69(1):506–508. doi: 10.1128/jvi.69.1.506-508.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jendroska K., Heinzel F. P., Torchia M., Stowring L., Kretzschmar H. A., Kon A., Stern A., Prusiner S. B., DeArmond S. J. Proteinase-resistant prion protein accumulation in Syrian hamster brain correlates with regional pathology and scrapie infectivity. Neurology. 1991 Sep;41(9):1482–1490. doi: 10.1212/wnl.41.9.1482. [DOI] [PubMed] [Google Scholar]
- Kimberlin R. H., Walker C. A. Intraperitoneal infection with scrapie is established within minutes of injection and is non-specifically enhanced by a variety of different drugs. Arch Virol. 1990;112(1-2):103–114. doi: 10.1007/BF01348988. [DOI] [PubMed] [Google Scholar]
- Kimberlin R. H., Walker C. A. Pathogenesis of mouse scrapie: effect of route of inoculation on infectivity titres and dose-response curves. J Comp Pathol. 1978 Jan;88(1):39–47. doi: 10.1016/0021-9975(78)90059-2. [DOI] [PubMed] [Google Scholar]
- Lazarini F., Deslys J. P., Dormont D. Variations in prion protein and glial fibrillary acidic protein mRNAs in the brain of scrapie-infected newborn mouse. J Gen Virol. 1992 Jul;73(Pt 7):1645–1648. doi: 10.1099/0022-1317-73-7-1645. [DOI] [PubMed] [Google Scholar]
- Masullo C., Macchi G., Xi Y. G., Pocchiari M. Failure to ameliorate Creutzfeldt-Jakob disease with amphotericin B therapy. J Infect Dis. 1992 Apr;165(4):784–785. doi: 10.1093/infdis/165.4.784. [DOI] [PubMed] [Google Scholar]
- McKenzie D., Kaczkowski J., Marsh R., Aiken J. Amphotericin B delays both scrapie agent replication and PrP-res accumulation early in infection. J Virol. 1994 Nov;68(11):7534–7536. doi: 10.1128/jvi.68.11.7534-7536.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Müller W. E., Ushijima H., Schröder H. C., Forrest J. M., Schatton W. F., Rytik P. G., Heffner-Lauc M. Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell cultures. Eur J Pharmacol. 1993 Aug 15;246(3):261–267. doi: 10.1016/0922-4106(93)90040-g. [DOI] [PubMed] [Google Scholar]
- Niki Y., Bernard E. M., Schmitt H. J., Tong W. P., Edwards F. F., Armstrong D. Pharmacokinetics of aerosol amphotericin B in rats. Antimicrob Agents Chemother. 1990 Jan;34(1):29–32. doi: 10.1128/aac.34.1.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Oesch B., Westaway D., Wälchli M., McKinley M. P., Kent S. B., Aebersold R., Barry R. A., Tempst P., Teplow D. B., Hood L. E. A cellular gene encodes scrapie PrP 27-30 protein. Cell. 1985 Apr;40(4):735–746. doi: 10.1016/0092-8674(85)90333-2. [DOI] [PubMed] [Google Scholar]
- Outram G. W. The pathogenesis of scrapie in mice. Front Biol. 1976;44:325–357. [PubMed] [Google Scholar]
- Pocchiari M., Casaccia P., Ladogana A. Amphotericin B: a novel class of antiscrapie drugs. J Infect Dis. 1989 Nov;160(5):795–802. doi: 10.1093/infdis/160.5.795. [DOI] [PubMed] [Google Scholar]
- Saint-Julien L., Joly V., Seman M., Carbon C., Yeni P. Activity of MS-8209, a nonester amphotericin B derivative, in treatment of experimental systemic mycoses. Antimicrob Agents Chemother. 1992 Dec;36(12):2722–2728. doi: 10.1128/aac.36.12.2722. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taraboulos A., Scott M., Semenov A., Avrahami D., Laszlo L., Prusiner S. B., Avraham D. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J Cell Biol. 1995 Apr;129(1):121–132. doi: 10.1083/jcb.129.1.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tokuda Y., Tsuji M., Yamazaki M., Kimura S., Abe S., Yamaguchi H. Augmentation of murine tumor necrosis factor production by amphotericin B in vitro and in vivo. Antimicrob Agents Chemother. 1993 Oct;37(10):2228–2230. doi: 10.1128/aac.37.10.2228. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vertut-Doï A., Ohnishi S. I., Bolard J. The endocytic process in CHO cells, a toxic pathway of the polyene antibiotic amphotericin B. Antimicrob Agents Chemother. 1994 Oct;38(10):2373–2379. doi: 10.1128/aac.38.10.2373. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Walker R. W., Rosenblum M. K. Amphotericin B-associated leukoencephalopathy. Neurology. 1992 Oct;42(10):2005–2010. doi: 10.1212/wnl.42.10.2005. [DOI] [PubMed] [Google Scholar]
- Wolf J. E., Massof S. E. In vivo activation of macrophage oxidative burst activity by cytokines and amphotericin B. Infect Immun. 1990 May;58(5):1296–1300. doi: 10.1128/iai.58.5.1296-1300.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Xi Y. G., Ingrosso L., Ladogana A., Masullo C., Pocchiari M. Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation. Nature. 1992 Apr 16;356(6370):598–601. doi: 10.1038/356598a0. [DOI] [PubMed] [Google Scholar]